Rumors and theories about an acquisition of Volcano Corporation (NASDAQ: VOLC) had been circulating for quite some time: months, years even. The company seemed an obvious choice: it has an advanced intravascular ultrasound (IVUS) technology that leads the market, with Boston Scientific coming in second; it has a fractional flow reserve (FFR) wire that splits the market with St. Jude Medical; and recently Volcano gained FDA approval for its Instant Wave-Free Ratio (iFR) physiologic measurement product, a faster, cheaper potential alternative to FFR. Continue reading
Category Archives: Global Trends
On October 23-25, 2014 the 3rd Advanced International Masterclass on the Transradial Approach will be held in Chicago and, if you already perform or want to start using the wrist approach to diagnostic or interventional procedures, you need to attend. Where else will you be able to spend two-and-a-half days with the most expert and experienced radial practitioners in the world?
I went to the very successful AimRADIAL course in New York City last fall and witnessed something I hadn’t really seen since the early days of angioplasty: a relatively small meeting (i.e. less than 300) attended by the pioneers of the procedure, cardiologists who have the largest experience in the radial approach, talking among themselves and trading their latest findings and techniques with each other, and sharing this information with the newer generation of physicians in attendance.It felt like an actual community! Continue reading
It’s been over 35 years since the first angioplasty was performed in Zurich by Dr. Andreas Gruentzig, but it was just yesterday that this minimally invasive procedure arrived in Australia’s Northern Territory.
Is the failure of the SYMPLICITY HTN-3 trial to meet its efficacy endpoint the “end of the road” for renal denervation? Will renal denervation now land on the heap of failed technologies? I don’t think so, and Dr. Darrel Francis, the cardiologist who famously predicted that SYMPLICITY HTN-3 would not meet its endpoint, agrees.
In fact Dr. Francis told Angioplasty.Org that it would be a “grave error” if the FDA withheld renal denervation from the American people, based on this news!
OK. Do I have your attention? Continue reading
A criticism from some cardiologists of the transradial approach, in which diagnostic angiography and percutaneous interventions (angioplasty and stents) are performed through the radial artery in the wrist, has been that the radial artery is too small to permit successful navigation of the various sheaths, wires and catheters. Of course, it’s been more than two decades since Dr. Ferdinand Kiemeneij successfully opened a blocked coronary artery via the wrist and today, in many parts of the world, half of all procedures are done this way. Continue reading
For the next three days, scores of interventional cardiologists will be gathering in New York City for the Second Annual AIM-RADIAL Master Class where they will hear talks, engage in roundtable discussions, watch live case demonstrations, and be thoroughly immersed in advanced state-of-the-art techniques, the latest data and the most current evidence-based medicine regarding all aspects of the transradial technique for diagnostic angiography and percutaneous interventions. Continue reading